p215-1 | "Interrogating clonal evolution of NPM1-mutant AML through genetic and genomic approaches" Dr. Linde Miles, Cincinnati Children's Hospital | Friday, June 13 |15:45-16:15 | Amber Hall 7+8
p473-1 | "Keynote lecture: Single cell and synthetic genomics of blood formation" Dr. Lars Velten, Centre for Genomic Regulation | Saturday, 14 June | 14:00-14:20 | Brown Hall 2
LB4002 | "INCA33989 is a novel, first in class, mutant calreticulin-specific monoclonal antibody that demonstrates safety and efficacy in patients with essential thrombocythemia (ET)" Dr. John Mascarenhas, Icahn School of Medicine at Mount Sinai | Sunday, June 15 | 09:15-10:45 | Late-Breaking Oral Session
PS1406 | "CXCR4 Expression in AML Blasts and its Impact on CXCR4 Inhibitor Efficacy During Consolidation Therapy: Results from the SAL Blast Trial." Saturday, 14 June | 18:30
PS1795 | "Single Cell Multiomic Analysis Uncovers Molecular and Clonal Events Associated with Ruxolitinib Treatment Response in Myelofibrosis." Saturday, 14 June | 18:30
PS1797 | "Characterization of CD9 as a novel marker for Disease-Propagating Stem Cells in Myelofibrosis." Saturday, 14 June | 18:30
PF447 | "Deciphering Clonal Heterogeneity in AML NPM1 Through Single Cell Multiomic Analysis." Friday, 13 June | 18:30
PF525 | "Three Patterns of Molecular Minimal Residual Disease Kinetics in Venetoclax + Azacitidine (V+A) Treated Acute Myeloid Leukemia (AML) Patients." Friday, 13 June | 18:30
PF617 | "High-throughput and Highly Sensitive Single Cell Genotyping with Simultaneous Chromatin Accessibility Profiling in Myeloid Precursor Conditions." Friday, 13 June | 18:30
